HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumor patients].

AbstractPURPOSE:
To know and to evaluate the opinion of cancer patients tumors who chose voluntarily to undergo the traditional anti-cancer treatment about Di Bella's therapy when the scientific debate was at its climax.
MATERIALS AND METHODS:
From March 1, 1998 to May 25, 1998 a questionnaire was distributed to 50 cancer patients. The questionnaire was anonymous, self-administered and included 9 questions.
RESULTS:
Overall, 35 (70%) patients were in favour of Di Bella's method.; 39 (78%) patients think that it is a successful step against cancer; 35 (70%) patients were willing to undergo the treatment.
CONCLUSIONS:
The main reasons for the complete trust in Di Bella's therapy were: mass media's power, Prof. Di Bella's image, the absence of toxicity in his therapy. These reasons will be reevaluated at the end of the trial.
AuthorsF Di Filippo, D Serraino, U Tirelli
JournalLa Clinica terapeutica (Clin Ter) 1998 Jul-Aug Vol. 149 Issue 4 Pg. 261-5 ISSN: 0009-9074 [Print] Italy
Vernacular TitleStudio di valutazione sulla percezione della multiterapia Di Bella (MDB) in pazienti con tumore.
PMID9866886 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Data Collection
  • Drug Evaluation
  • Female
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Neoplasms (drug therapy)
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: